SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-21-108742
Filing Date
2021-08-24
Accepted
2021-08-24 06:03:38
Documents
1
Group Members
SENJU PHARMACEUTICAL CO., LTD

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2125648d1_sc13da.htm SC 13D/A 59192
  Complete submission text file 0001104659-21-108742.txt   60498
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Subject) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90395 | Film No.: 211198406
SIC: 2834 Pharmaceutical Preparations

Mailing Address 501 FIFTH AVENUE SUITE 1404 NEW YORK NY 10017
Business Address
Yoshida Shuhei (Filed by) CIK: 0001728901 (see all company filings)

Type: SC 13D/A